2,6-Bis-chloromethyl-1,7-dimethyl-1H,7H-benzo[1,2-d;4,5-d']diimidazole-4,8-dione

ID: ALA158122

PubChem CID: 10267558

Max Phase: Preclinical

Molecular Formula: C12H10Cl2N4O2

Molecular Weight: 313.14

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1c(CCl)nc2c1C(=O)c1c(nc(CCl)n1C)C2=O

Standard InChI:  InChI=1S/C12H10Cl2N4O2/c1-17-5(3-13)15-7-9(17)12(20)10-8(11(7)19)16-6(4-14)18(10)2/h3-4H2,1-2H3

Standard InChI Key:  BALDHZXOSZRRLN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    4.7750   -1.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2042   -1.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7792   -2.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2042   -2.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -2.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9917   -1.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9792   -1.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -1.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9917   -2.6667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0000   -2.6792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4667   -2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5042   -2.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -3.6542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -0.3542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2917   -1.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6792   -2.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7417   -3.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2500   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2667   -1.3042    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    8.7125   -2.7042    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  8  1  0
  3  1  2  0
  4  2  2  0
  5  3  1  0
  6  1  1  0
  7  2  1  0
  8  1  1  0
  9  4  1  0
 10  3  1  0
 11  7  2  0
 12  6  2  0
 13  5  2  0
 14  8  2  0
 15 11  1  0
 16 12  1  0
 17 10  1  0
 18  9  1  0
 19 16  1  0
 20 15  1  0
 10 12  1  0
  4  5  1  0
 11  9  1  0
M  END

Associated Targets(Human)

Panel leukemia (Carcinoma cell lines) (209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSCLC (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Colon carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNS carcinoma cell (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Melanoma cell (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ovarian carcinoma cell (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Renal cancer cell line (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 313.14Molecular Weight (Monoisotopic): 312.0181AlogP: 1.41#Rotatable Bonds: 2
Polar Surface Area: 69.78Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.27CX LogP: 1.06CX LogD: 1.06
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.67Np Likeness Score: -0.11

References

1. Schulz WG, Skibo EB..  (2000)  Inhibitors of topoisomerase II based on the benzodiimidazole and dipyrroloimidazobenzimidazole ring systems: controlling DT-diaphorase reductive inactivation with steric bulk.,  43  (4): [PMID:10691689] [10.1021/jm990210q]

Source